We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.de Bruijn, SF, de Haan, RJ, Stam, J.Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry2001;70(1):105–8.CrossRefGoogle Scholar
2
2.Reuner, KH, Ruf, A, Grau, A, Rickmann, H, Stolz, E, Juttler, E, et al. Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosis. Stroke1998;29(19):1765–9.Google Scholar
3
3.Junker, R, Nabavi, DG, Wolff, E, Ludemann, P, Nowak-Gottl, U, Kase, M.et al. Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thromb Haemost1998;80(4):706–7.Google Scholar
4
4.de Bruijn, SF, Stam, J, Vandenbroucke, JP.Increased risk of cerebral venous thrombosis with third-generation oral contraceptives [letter]. Cerebral Venous Sinus Thrombosis Study Group. Lancet1998;351:1404.Google Scholar
6.Madan, A, Sluzewski, M, van Rooij, WJ, Tijssen, CC, Teepen, JL.Thrombosis of the deep cerebral veins: CT and MRI findings with pathologic correlation. Neuroradiology1997;39:777–80.Google Scholar
7
7.Padayachee, TS, Bingham, JB, Graves, MJ, Colchester, AC, Cox, TC.Dural sinus thrombosis. Diagnosis and follow-up by magnetic resonance angiography and imaging. Neuroradiology1991;33:165–7.CrossRefGoogle ScholarPubMed